<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00110630</url>
  </required_header>
  <id_info>
    <org_study_id>NIDA-15774-2</org_study_id>
    <secondary_id>K23-15774-2</secondary_id>
    <nct_id>NCT00110630</nct_id>
  </id_info>
  <brief_title>Smoking Treatment of Prisoners</brief_title>
  <acronym>STOP</acronym>
  <official_title>Smoking Treatment of Prisoners: Project &quot;STOP&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>GlaxoSmithKline</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>National Institute on Drug Abuse (NIDA)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the efficacy of a 10-week smoking cessation therapy
      combined with NicoDerm CQ for smoking cessation among female prisoners.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a randomized controlled trial utilizing a wait-list control group to examine 10-week
      group therapy and nicotine replacement compared to wait-list for smoking cessation among
      female prisoners.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2005</start_date>
  <completion_date type="Actual">September 2007</completion_date>
  <primary_completion_date type="Actual">September 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>smoking cessation</measure>
  </primary_outcome>
  <enrollment type="Actual">250</enrollment>
  <condition>Tobacco Use Cessation</condition>
  <condition>Tobacco Use Disorder</condition>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>10-week smoking cessation group therapy combined with NicoDerm CQ</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1) current smoker and (2) seeking group treatment to quit smoking.

        Exclusion Criteria:

          -  (1) non-english speaking, (2) housed in segregation, (3) presence of active, severe
             mental illness as defined by active psychosis, manic episode, or imminently
             suicidal/homicidal, (4) mental retardation such that they cannot provide informed
             consent, and (5) due to be released or transferred to another facility within the next
             year.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen Cropsey, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Commonwealth University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23298</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2005</study_first_submitted>
  <study_first_submitted_qc>May 10, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 11, 2005</study_first_posted>
  <last_update_submitted>January 11, 2017</last_update_submitted>
  <last_update_submitted_qc>January 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 12, 2017</last_update_posted>
  <responsible_party>
    <name_title>Karen Cropsey</name_title>
    <organization>Univeristy of Alabama at Birmingham</organization>
  </responsible_party>
  <keyword>nicotine dependence</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

